Literature DB >> 18097326

Successful video-assisted thoracic surgery lobectomy in a single-lung patient.

Ryoichi Nakanishi1, Ayako Hirai, Kenji Muranaka, Koichi Shinohara.   

Abstract

In terms of perioperative management, it is extremely difficult to perform a video-assisted thoracic surgery lobectomy for primary lung cancer in patients previously undergoing a contralateral pneumonectomy. We herein describe the successful video-assisted thoracic surgery lobectomy with systematic mediastinal lymph node dissection in a single-lung patient with clinical stage IA nonsmall cell lung cancer. Our experience indicates surgeons may consider the procedure if the following conditions are met: (1) satisfactory pulmonary function, (2) the selective bronchial blockade of the lobe to be resected, and (3) the effective retraction of the inflated lung.

Entities:  

Mesh:

Year:  2007        PMID: 18097326     DOI: 10.1097/SLE.0b013e31813e66d3

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  4 in total

1.  Awake thoracoscopic surgery under epidural anesthesia: is it really safe?

Authors:  Ryoichi Nakanishi; Manabu Yasuda
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

2.  Video-assisted thoracic surgery involving major pulmonary resection for central tumors.

Authors:  Ryoichi Nakanishi; Yoshihisa Fujino; Soichi Oka; Seiichi Odate
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

3.  Thoracoscopic wedge resection in single-lung patients.

Authors:  Davide Zampieri; Giuseppe Marulli; Giovanni Maria Comacchio; Marco Schiavon; Andrea Zuin; Federico Rea
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  Contralateral pulmonary resection using selective bronchial blockade in postpneumonectomy patients.

Authors:  Nobutaka Kawamoto; Masashi Furukawa; Riki Okita; Masanori Okada; Masataro Hayashi; Hidetoshi Inokawa; Kazunori Okabe; Keisuke Kawata
Journal:  Thorac Cancer       Date:  2020-10-13       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.